Genome imprinting has an essential role in normal embryonal mammalian
development. Starting early in differentiation, the transcripts of cer
tain human genes, e.g. the paternally-H-19 and the maternally-imprinte
d IGF2, are expressed in specific tissues and organs during fetal life
. In several malignant disorders, imprinted genes are, again, unfolded
. Characteristically, expression follows the same tissue presentation
as during embryogenesis. Clinical paternal disomies, i.e. trophoblasti
c diseases, and their maternal counterpart, i.e. ovarian teratomas, ar
e associated with apparent relaxation of imprinting once they turn mal
ignant. Paediatric neoplasms, like Wilm's tumor (WT) and rhabdomyosarc
oma, often express IGF2 and H-19. Recently, we have found H-19 express
ion in invasive urothelial cancer. Evidently, imprinted genes display
an oncodevelopmental mode of expression, very much like the classical
oncofetal proteins AFP and CEA. Based on available data, including tum
or preferential paternal allele retention and chromosome 11 short arm
physical linkage with oncogenes like H-ras, we hypothesize that imprin
ted genes not only accompany cancer but may play a causative role as w
ell.